Renovia Inc. is a health care startup that aims to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Founded in 2016, Renovia is the maker of the leva® Pelvic Health System, which is a novel and effective first-line treatment for female urinary incontinence. The company's technology allows for precise visualization of pelvic movement in real-time during pelvic floor muscle training, as well as monitoring usage and progress over time.
Renovia's commitment to women's health is reflected in its pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
This dedication has attracted significant investment, with a $17.00M Series C investment received on 19 April 2021. This round of investment was led by a group of prominent investors including Longwood Fund, Ascension Ventures, OSF Healthcare, Parian Global Management, and Perceptive Advisors. With its innovative product and strong investor backing, Renovia Inc. appears well-positioned to make a significant impact in the health care industry and improve the lives of women worldwide.No recent news or press coverage available for Renovia Inc..